Ticker
KALVCompany Name
KALVISTA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 215.5M | $ 124.3M | 57.68% |
3/31/2025 | $ 250.77M | $ 131.62M | 52.48% |
12/31/2024 | $ 275.99M | $ 167.29M | 60.61% |
9/30/2024 | $ 160.83M | $ 41.58M | 25.85% |
6/30/2024 | $ 200.2M | $ 31.85M | 15.91% |
3/31/2024 | $ 235.4M | $ 31.79M | 13.5% |
12/31/2023 | $ 113.97M | $ 23.06M | 20.23% |
9/30/2023 | $ 138.74M | $ 57.67M | 41.56% |
6/30/2023 | $ 160.33M | $ 49.41M | 30.82% |
3/31/2023 | $ 183.2M | $ 56.24M | 30.7% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for KALVISTA PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 16.17M ] / Assets [ $ 75.45M ]
(=) Cash to Assets [ 21.44% ]
Minimum
Mar 31, 2024
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.92% |
average | 9.84% |
median | 6.44% |
std | 9.62% |